Searched for
CLINICAL TRIALS AND AI
AI-Powered drug discovery could transform treatment development for Alzheimer’s, Parkinson’s and other brain disorders.Researchers are increasingly using AI to accelerate the search for treatments for neurological conditions such as Alzheimer’s, Parkinson’s,...- From diapers to drugs: How India's global corporate hubs are putting AI to workHeads of several Global Capability Centres (GCCs) told Reuters they are deploying AI across a host of functions - from marketing and conten...
- Saving supply chains from climate shocks is a lure for investorsCompanies are increasingly focused on supply chain resilience. This trend is expected to continue, offering new opportunities and protectin...
- Novo Nordisk uses AI to fast-track drug launches, expand India roleNovo Nordisk is leveraging Artificial Intelligence to significantly speed up new drug launches. The company expects to cut down the time to...
- Want to jump into the 'China is back' rally? Tread carefullyInvestors are increasingly betting that “China is back” as the economy rebounds from years of deflation, helped by strong manufacturing, ex...
- DeepMind CEO Demis Hassabis’ Isomorphic Labs raises $2.1 billion led by Thrive CapitalAI-driven drug discovery firm Isomorphic Labs secured a massive $2.1 billion in Series B funding. This capital will fuel the expansion of t...
- As US reboots psychedelics from counterculture to R&D, Indian pharma must take the leadThe United States is accelerating research into psychedelic drugs for mental illness. This shift prompts India to re-evaluate its own drug ...
- ET Most Innovative AI Product Awards 2026: Honouring AI Innovations reshaping Life Sciences & Pharma ResearchThe Life Sciences & Pharma category at the ET Most Innovative AI Product Awards 2026. Recognises organisations leveraging AI to accelerate ...
- J&J sees AI halving the time to generate drug development leadsJohnson & Johnson is leveraging artificial intelligence to significantly speed up drug development. The company has halved the time needed ...
- Brain health startup Ivory develops 'treadmill test' for brain; focusses on cognitive health in IndiaThe AI-powered startup offers cognitive assessments measuring attention, memory, and executive function, providing users with benchmarked s...
- Amazon launches AI research tool to speed early-stage drug discoveryAmazon Web Services has launched Amazon Bio Discovery, an AI tool to accelerate drug discovery. Scientists can now generate and evaluate po...
- Anthropic acquires Coefficient Bio for nearly $400 million: ReportAnthropic acquires startup Coefficient Bio for about $400 million: report
- Beijing-backed brain chip firm says it is 3 years behind Elon Musk's NeuralinkNeuCyber's frontier Beinao-2 product is an invasive BCI with flexible electrodes that fully implant into the brain, currently undergoing ...
- Roche ramps up AI computing capacity with Nvidia chip expansionRoche said the additional hardware would speed up work across its research and development operations, including modelling, data analysis...
- India becoming backbone of global clinical researchIndia has emerged as a key player in international clinical trials, showcasing resilience even in the face of global hurdles. With research...
- Drugmakers turn to AI to speed trials, regulatory submissionsAI is helping find participants and sites for clinical trials and drafting documents for regulators, shaving weeks off these labor-intensi...
- Sharp companies leverage data to build out healthcare LLMsCompanies like Harman and Vizzhy leverage healthcare data to create large language models (LLMs) for hospitals. These LLMs automate hospita...
- Predictions of AI-powered models strictly trial-specific, have no generalisability: StudyResearchers said the study showed that generalisations of predictions of artificial intelligence-based models across different study centre...
- Eyestem partners with RetinAI for treatment of geographic atrophy with AI techGeographic atrophy can lead to irreversible loss of vision over time and currently affects 200 million people globally.
- AI startup Unlearn raises $15 million in funding, adds OpenAI CTO Mira Murati to boardMira Murati, chief technology officer at Microsoft-backed OpenAI, is joining the startup's board.
Load More
